These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 1387799

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ, Sleph PG, Dzwonczyk S, Wang P, Fung W, Tobias D, Cushman DW.
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
    Przyklenk K, Kloner RA.
    Am Heart J; 1991 May; 121(5):1319-30. PubMed ID: 1850188
    [Abstract] [Full Text] [Related]

  • 4. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
    Ferrari R, Cargnoni A, Curello S, Ceconi C, Boraso A, Visioli O.
    J Cardiovasc Pharmacol; 1992 May; 20(5):694-704. PubMed ID: 1280730
    [Abstract] [Full Text] [Related]

  • 5. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
    Westlin W, Mullane K.
    Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
    [Abstract] [Full Text] [Related]

  • 6. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW, Wang FL, Fung WC, Grover GJ, Harvey CM, Scalese RJ, Mitch SL, DeForrest JM.
    Br J Clin Pharmacol; 1989 Jun; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of zofenopril in myocardial protection during cardioplegia arrest: an isolated rat heart model.
    Leva C, Mariscalco G, Ferrarese S, Bruno VD, Orrù A, Cattaneo P, Sala A.
    J Card Surg; 2006 Jun; 21(1):44-9. PubMed ID: 16426347
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
    Chen H, Mohuczy D, Li D, Kimura B, Phillips MI, Mehta P, Mehta JL.
    Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
    [Abstract] [Full Text] [Related]

  • 11. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
    de Nigris F, D'Armiento FP, Somma P, Casini A, Andreini I, Sarlo F, Mansueto G, De Rosa G, Bonaduce D, Condorelli M, Napoli C.
    Int J Cardiol; 2001 Dec; 81(2-3):107-15; discusssion 115-6. PubMed ID: 11744122
    [Abstract] [Full Text] [Related]

  • 12. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors.
    Chopra M, Beswick H, Clapperton M, Dargie HJ, Smith WE, McMurray J.
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):330-40. PubMed ID: 1378110
    [Abstract] [Full Text] [Related]

  • 13. Captopril in cardioplegia and reperfusion: protective effects on the ischemic heart.
    Gurevitch J, Pevni D, Frolkis I, Matsa M, Paz Y, Mohr R, Yakirevich V.
    Ann Thorac Surg; 1997 Mar; 63(3):627-33. PubMed ID: 9066375
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhanced prostaglandin production in the ischemic-reperfused myocardium by captopril linked with its free radical scavenging action.
    Bagchi D, Iyengar J, Stockwell P, Das DK.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Nov; 38(2):145-50. PubMed ID: 2694179
    [Abstract] [Full Text] [Related]

  • 16. Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion.
    Frascarelli S, Ghelardoni S, Ronca-Testoni S, Zucchi R.
    J Cardiovasc Pharmacol; 2004 Feb; 43(2):294-9. PubMed ID: 14716220
    [Abstract] [Full Text] [Related]

  • 17. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
    Sarro GD, Paola ED, Gratteri S, Gareri P, Rispoli V, Siniscalchi A, Tripepi G, Gallelli L, Citraro R, Russo E.
    Pharmacol Res; 2012 Mar; 65(3):285-96. PubMed ID: 22107891
    [Abstract] [Full Text] [Related]

  • 18. The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig.
    Tio RA, de Langen CD, de Graeff PA, van Gilst WH, Bel KJ, Wolters KG, Mook PH, van Wijngaarden J, Wesseling H.
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):695-703. PubMed ID: 2076380
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.